DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Stan Marsh - 1 Clyde Donovan - 1 Clyde - 1 Stan - 1 OpenAI - 1 it's - 1 Dmitri Mirakyan - 1 YourMove - 1
Top related locs:
U.S New York chihuahua Finland Australia New Zealand Netherlands Geneva
Top related orgs:
Nvidia - 1 CNBC - 1 Nurphoto - 1 OpenAI's - 1 Memory Centre - 1 of Readaptation - 1 University Hospital - 1 REUTERS - 1

Search resuls for: "Kremen"


3 mentions found


☆ AI is shaking up online dating with chatbots that are 'flirty but not too flirty'
  + stars: | 2024-02-14 | by ( Hayden Field | ) www.cnbc.com   time to read: +10 min
YourMove.AI, an AI dating tool that offers a range of services such as drafting messages, analyzing conversations and evaluating users' dating app profiles, has about 250,000 users, founder Dmitri Mirakyan estimates. Rizz, an AI dating assistant, debuted in 2022 after ChatGPT took off. Like in other areas, relying too much on AI in dating can cross the line into unethical behavior. Although the use of AI for dating purposes isn't necessarily all bad, he added, dating apps will still need to "tread with caution." WATCH: How I built my $400 million-a-year dating app
Persons: Stan Marsh, Clyde Donovan, Clyde, Stan, OpenAI, it's, Dmitri Mirakyan, YourMove, Mirakyan, ChatGPT, he'd, Roman Khaves, Josh Miller, Khaves, It's, Jonathan Raa, Alex Weitzman, Weitzman, They've, Gary Kremen, Kremen, Lisa Marie Bobby, Bobby, Renate Nyborg, Nyborg, Meeno Organizations: Nvidia, CNBC, Nurphoto, OpenAI's Locations: U.S, New York, chihuahua, Finland, Australia, New Zealand, Netherlands
☆ Blood tests needed for widespread Alzheimer's diagnosis on the way
  + stars: | 2023-10-11 | by ( Deena Beasley | ) www.reuters.com   time to read: +6 min
Several Alzheimer's blood tests are in the works – and one is already being sold to consumers – but none have been established as accurate, formally approved by regulators or reimbursed by insurers. Researchers have been working for years on blood tests for Alzheimer's that can replicate these diagnostic tools. The need for blood tests has become more pressing since the FDA approved Leqembi in July. Accurate blood tests are expected to help identify which dementia patients actually have Alzheimer’s, the most common but not the only cause of dementia. "When there are widely available, scalable, sensitive and specific blood tests it will be an absolute game changer for Alzheimer's patients."
Persons: Denis Balibouse, Eli Lilly, Dr, Sarah Kremen, Eliezer Masliah, Eisai, Michael Irizarry, Roche, Bruce Jordan, Russ Paulsen, Deena Beasley, Caroline Humer, Bill Berkrot Organizations: Memory Centre, of Readaptation, University Hospital, REUTERS, FDA, Sinai Medical Center, Wednesday, Quest Diagnostics, National Institute, Aging, U.S . National Institutes of Health, C2N Diagnostics, Roche Diagnostics, Alzheimer's Association, RAND, Thomson Locations: Geneva, Switzerland, Leqembi, Eisai, Los Angeles, U.S
☆ 'It totally backfired': The pitfalls of Alzheimer's genetic testing
  + stars: | 2023-04-21 | by ( Julie Steenhuysen | ) www.reuters.com   time to read: +8 min
CHICAGO, April 21 (Reuters) - Wendy Nelson watched her mother slowly die of Alzheimer's disease, unable to move or swallow at the end. When her father's memory began to fail a year later, one of her two sisters doubted it could be Alzheimer's, Nelson said. THE TESTING REVOLUTIONUntil recently, most doctors tended not to order genetic tests to determine Alzheimer's risk, because there were no effective treatments to slow or prevent the disease. US regulators recommend genetic testing before starting treatment with Leqembi. Some members of families with increased genetic risk of Alzheimer's say it might be better not to know at all.
0 next >>
Total: 3